Benitec Biopharma (BNTC) Non-Current Assets (2019 - 2025)
Benitec Biopharma (BNTC) posted Non-Current Assets of $1.1 million for Q4 2025, up 14.56% sequentially from $948000.0 in Q3 2025, and up 205.92% YoY from $355000.0 in Q4 2024.
Benitec Biopharma (BNTC) Non-Current Assets (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Non-Current Assets for 7 years, with the latest figure at $1.1 million in Q4 2025.
- Quarterly Non-Current Assets rose 205.92% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$100.9 million (down 5240.19% YoY) and the FY2025 annual result came in at $1.1 million, up 100.37% from the prior year.
- Non-Current Assets grew to $1.1 million in Q4 2025 per BNTC's latest filing, from $948000.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $1.5 million in Q3 2021 and troughed at -$104.0 million in Q1 2025.
- A 5-year average of -$4.4 million and a median of $877500.0 in 2022 frame the typical range for Non-Current Assets.
- The widest YoY moves for Non-Current Assets: up 205.92% in 2025, down 16531.28% in 2025.
- Over 5 years, Non-Current Assets stood at $1.3 million in 2021, then plunged by 30.7% to $930000.0 in 2022, then plunged by 40.11% to $557000.0 in 2023, then slumped by 36.27% to $355000.0 in 2024, then surged by 205.92% to $1.1 million in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.1 million, $948000.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 948,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | -104.01 Mn |
| Dec 31, 2024 | 355,000.00 |
| Sep 30, 2024 | 439,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Mar 31, 2024 | 633,000.00 |
| Dec 31, 2023 | 557,000.00 |
| Sep 30, 2023 | 641,000.00 |
| Jun 30, 2023 | 735,000.00 |
| Mar 31, 2023 | 825,000.00 |
| Dec 31, 2022 | 930,000.00 |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 1.15 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 771,000.00 |
| Mar 31, 2021 | 1.02 Mn |